ATMIN: A New Tumor Suppressor in Developing B Cells

Abstract

In the current issue of Cancer Cell, Loizou et al. report that the deletion of ATM Interactor (ATMIN) in developing B cells leads to profound genomic instability and clonal B cell leukemia, revealing a novel tumor suppressor function for ATMIN. In the current issue of Cancer Cell, Loizou et al. report that the deletion of ATM Interactor (ATMIN) in developing B cells leads to profound genomic instability and clonal B cell leukemia, revealing a novel tumor suppressor function for ATMIN. Lymphocyte development requires ordered assembly of the antigen receptor loci through V(D)J recombination. B lymphocytes also undergo additional gene modifications—somatic hypermutation (SHM) and class switch recombination (CSR)—to achieve high affinity and diverse effector functions (Nussenzweig and Nussenzweig, 2010Nussenzweig A. Nussenzweig M.C. Cell. 2010; 141: 27-38Abstract Full Text Full Text PDF PubMed Scopus (233) Google Scholar). V(D)J recombination and CSR both entail the formation of DNA double strand breaks (DSBs) as an obligate intermediate, invoke strong DNA damage responses, and require efficient DSB repair for completion (Gostissa et al., 2011Gostissa M. Alt F.W. Chiarle R. Annu. Rev. Immunol. 2011; 29: 319-350Crossref PubMed Scopus (121) Google Scholar). In repair-deficient cells, unrepaired DSBs generated during V(D)J recombination and CSR often participate in oncogenic chromosomal translocations that eventually lead to malignant transformation, especially in the absence of an appropriate checkpoint response (Gostissa et al., 2011Gostissa M. Alt F.W. Chiarle R. Annu. Rev. Immunol. 2011; 29: 319-350Crossref PubMed Scopus (121) Google Scholar). Indeed, aberrant resolution of these DSBs is likely responsible for many of the recurrent chromosomal translocations characteristic of human lymphoid malignancies (Nussenzweig and Nussenzweig, 2010Nussenzweig A. Nussenzweig M.C. Cell. 2010; 141: 27-38Abstract Full Text Full Text PDF PubMed Scopus (233) Google Scholar). The ATM kinase is a master regulator of the DNA damage response. Physiological DSBs generated during V(D)J recombination and CSR signal through the MRN (MRE11-RAD50-NBS1) complex to activate ATM, which then phosphorylates substrates involved in both DNA repair and cell-cycle checkpoint control (Figure 1) (Lavin, 2008Lavin M.F. Nat. Rev. Mol. Cell Biol. 2008; 9: 759-769Crossref PubMed Scopus (732) Google Scholar). Recent studies indicate that the ATM kinase can also be activated independent of DSBs, such as under hypotonic conditions or with chloroquine, although the molecular mechanism and physiological significance of DSB-independent ATM activation remain unclear (Lavin, 2008Lavin M.F. Nat. Rev. Mol. Cell Biol. 2008; 9: 759-769Crossref PubMed Scopus (732) Google Scholar). In human patients, homozygous inactivation of ATM causes Ataxia Telangiectasia, a rare genetic syndrome associated with genomic instability and predisposition to lymphoid malignancies. Somatic inactivation of ATM has been reported in many human cancers, including a subset of B and T cell malignancies (Boultwood, 2001Boultwood J. J. Clin. Pathol. 2001; 54: 512-516Crossref PubMed Scopus (114) Google Scholar). The ATM Interactor (ATMIN, also called ASCIZ) is a nuclear Zn2+ finger protein with a C-terminal cluster of SQ/TQ motifs that can be phosphorylated by ATM and ATM-related kinases (Kanu and Behrens, 2007Kanu N. Behrens A. EMBO J. 2007; 26: 2933-2941Crossref PubMed Scopus (67) Google Scholar, McNees et al., 2005McNees C.J. Conlan L.A. Tenis N. Heierhorst J. EMBO J. 2005; 24: 2447-2457Crossref PubMed Scopus (43) Google Scholar). ATMIN binds to ATM under basal conditions and has been proposed to regulate ATM activity upon hypotonic stress (Kanu and Behrens, 2007Kanu N. Behrens A. EMBO J. 2007; 26: 2933-2941Crossref PubMed Scopus (67) Google Scholar). In the current issue of Cancer Cell, Loizou et al., 2011Loizou J.I. Sancho R. Kanu N. Bolland D.J. Yang F. Rada C. Corcoran A.E. Behrens A. Cancer Cell. 2011; 19 (this issue): 587-600Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar report that inactivation of ATMIN in developing B cells leads to a 50% reduction in CSR. The CSR defects in ATMIN-deficient B cells are accompanied by general genomic instability as well as antigen receptor locus-specific breaks (Loizou et al., 2011Loizou J.I. Sancho R. Kanu N. Bolland D.J. Yang F. Rada C. Corcoran A.E. Behrens A. Cancer Cell. 2011; 19 (this issue): 587-600Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar). This phenotype is very similar, though less severe than that described for ATM-deficient B cells (Lavin, 2008Lavin M.F. Nat. Rev. Mol. Cell Biol. 2008; 9: 759-769Crossref PubMed Scopus (732) Google Scholar). Moreover, up to 40% of mice with B cell-specific deletion of ATMIN developed B lymphoma within six months (Loizou et al., 2011Loizou J.I. Sancho R. Kanu N. Bolland D.J. Yang F. Rada C. Corcoran A.E. Behrens A. Cancer Cell. 2011; 19 (this issue): 587-600Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar), revealing a strong tumor suppressor function of ATMIN. What do these observations reveal about the functions of ATMIN and its relationship to ATM? Loizou et al., 2011Loizou J.I. Sancho R. Kanu N. Bolland D.J. Yang F. Rada C. Corcoran A.E. Behrens A. Cancer Cell. 2011; 19 (this issue): 587-600Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar observed that focus formation by activated ATM (p-S1987) is reduced in ATMIN-deficient B cells, suggesting suboptimal ATM activation. While DSBs generated during CSR were thought to be the primary signal for ATM activation, Loizou et al., 2011Loizou J.I. Sancho R. Kanu N. Bolland D.J. Yang F. Rada C. Corcoran A.E. Behrens A. Cancer Cell. 2011; 19 (this issue): 587-600Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar show that ATM is activated normally in ATMIN-deficient B cells by DSBs but not by hypotonic stress. Therefore, they propose that DSB-independent activation of ATM via ATMIN ensures robust ATM activity for efficient DNA repair in switching B cells (Figure 1). Although hypotonic stress was proposed to activate ATM by altering chromatin structure, the physiological stimulus that triggers ATMIN-dependent ATM activation in switching B cells remains unclear. During both V(D)J recombination and CSR, the formation of DSBs by lymphocyte-specific factors (i.e., RAG or AID) is accompanied by well-documented chromatin movements (e.g., looping, pairing) and histone modifications, which could potentially stimulate ATMIN-dependent activation of ATM, independent of DSBs (Gostissa et al., 2011Gostissa M. Alt F.W. Chiarle R. Annu. Rev. Immunol. 2011; 29: 319-350Crossref PubMed Scopus (121) Google Scholar). In this context, ATMIN-deficient B cells should provide a unique platform to address the molecular mechanisms of DSB-independent ATM activation in DNA repair and tumor suppression. Curiously, while ATMIN is required for ATM activation by hypotonic stress in B cells (Loizou et al., 2011Loizou J.I. Sancho R. Kanu N. Bolland D.J. Yang F. Rada C. Corcoran A.E. Behrens A. Cancer Cell. 2011; 19 (this issue): 587-600Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar), studies on ATMIN-deficient fibroblasts have yielded conflicting results, with one group observing profound defects in hypotonic stress-induced ATM activation (Kanu and Behrens, 2007Kanu N. Behrens A. EMBO J. 2007; 26: 2933-2941Crossref PubMed Scopus (67) Google Scholar), and another group reporting no defects (Jurado et al., 2010Jurado S. Smyth I. van Denderen B. Tenis N. Hammet A. Hewitt K. Ng J.L. McNees C.J. Kozlov S.V. Oka H. et al.PLoS Genet. 2010; 6: e1001170Crossref PubMed Scopus (32) Google Scholar). Identifying the physiological signal that triggers ATMIN-dependent activation of ATM in B cells may also help resolve this disparity. Since ATMIN has multiple SQ/TQ motifs (15–18, depending on species) and is phosphorylated by ATM in vivo (McNees et al., 2005McNees C.J. Conlan L.A. Tenis N. Heierhorst J. EMBO J. 2005; 24: 2447-2457Crossref PubMed Scopus (43) Google Scholar), it could also function downstream of ATM in DNA repair and checkpoint control (Figure 1). ATMIN is recruited to nuclear foci after methyl methanesulfonate (MMS) treatment, and ATMIN-deficient cells display hypersensitivity to H2O2 and MMS, reduced RAD51-focus formation, and defects in base excision repair (Jurado et al., 2010Jurado S. Smyth I. van Denderen B. Tenis N. Hammet A. Hewitt K. Ng J.L. McNees C.J. Kozlov S.V. Oka H. et al.PLoS Genet. 2010; 6: e1001170Crossref PubMed Scopus (32) Google Scholar, Kanu and Behrens, 2007Kanu N. Behrens A. EMBO J. 2007; 26: 2933-2941Crossref PubMed Scopus (67) Google Scholar, Kanu et al., 2010Kanu N. Penicud K. Hristova M. Wong B. Irvine E. Plattner F. Raivich G. Behrens A. J. Biol. Chem. 2010; 285: 38534-38542Crossref PubMed Scopus (43) Google Scholar, McNees et al., 2005McNees C.J. Conlan L.A. Tenis N. Heierhorst J. EMBO J. 2005; 24: 2447-2457Crossref PubMed Scopus (43) Google Scholar). Nonetheless, it is still unclear whether ATM phosphorylation of ATMIN plays a role in these processes. Interestingly, unlike other ATM substrates (e.g., H2AX), ATMIN is significantly phosphorylated under basal conditions (McNees et al., 2005McNees C.J. Conlan L.A. Tenis N. Heierhorst J. EMBO J. 2005; 24: 2447-2457Crossref PubMed Scopus (43) Google Scholar), though the functions of basal ATMIN phosphorylation are not known. In addition, ATMIN may also participate in the DNA damage response indirectly through interaction with other ATM substrates, such as CHK2 (McNees et al., 2005McNees C.J. Conlan L.A. Tenis N. Heierhorst J. EMBO J. 2005; 24: 2447-2457Crossref PubMed Scopus (43) Google Scholar). Although ATM null mice are viable (Lavin, 2008Lavin M.F. Nat. Rev. Mol. Cell Biol. 2008; 9: 759-769Crossref PubMed Scopus (732) Google Scholar), ATMIN null mice are embryonic lethal with severe pulmonary developmental defects (Jurado et al., 2010Jurado S. Smyth I. van Denderen B. Tenis N. Hammet A. Hewitt K. Ng J.L. McNees C.J. Kozlov S.V. Oka H. et al.PLoS Genet. 2010; 6: e1001170Crossref PubMed Scopus (32) Google Scholar, Kanu et al., 2010Kanu N. Penicud K. Hristova M. Wong B. Irvine E. Plattner F. Raivich G. Behrens A. J. Biol. Chem. 2010; 285: 38534-38542Crossref PubMed Scopus (43) Google Scholar). As such, ATMIN clearly has ATM-independent functions (Figure 1), some of which may potentially contribute to tumor suppression. Despite less severe CSR defects, more than 40% of mice with B cell specific deletion of ATMIN succumbed to B cell lymphomas within a year (Loizou et al., 2011Loizou J.I. Sancho R. Kanu N. Bolland D.J. Yang F. Rada C. Corcoran A.E. Behrens A. Cancer Cell. 2011; 19 (this issue): 587-600Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar), while germline ATM null mice succumb to T cell lymphomas between 3 and 9 months, with no documented B cell tumors (Lavin, 2008Lavin M.F. Nat. Rev. Mol. Cell Biol. 2008; 9: 759-769Crossref PubMed Scopus (732) Google Scholar). Mice carrying a hypomorphic ATM mutation (equivalent to 7636del9 in human) do develop B cell malignancies but with a long latency (>40 weeks) and low penetrance (3 out of 40). Why ATMIN deficiency seemly promotes B cell lymphomas in mice more efficiently than does ATM deficiency is unknown and of considerable interest. In particular, human patients with germline ATM mutations do develop B cell lymphomas. Notably, ATMIN-deficient B cell lymphomas display diverse surface phenotypes, ranging from those of early native B cell to those of plasma cells, and have various chromosomal translocations, most of which do not involve immunoglobulin loci. Molecular characterization of the translocation junctions and the development stages (e.g., light chain rearrangement, somatic hypermutation status) would shed some lights on how ATMIN executes tumor suppressor function and how it is related to ATM function in B cells. Somatic mutations of ATM are found in a broad spectrum of human cancers, whereas tumor-specific lesions of ATMIN have not been reported in human cancers so far. Nevertheless, given its role in DNA repair and tumor suppression reported by Loizou et al., 2011Loizou J.I. Sancho R. Kanu N. Bolland D.J. Yang F. Rada C. Corcoran A.E. Behrens A. Cancer Cell. 2011; 19 (this issue): 587-600Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar, ATMIN may also serve as a suppressor of human tumor development and, as such, a potential target for therapeutic intervention. The study by Loizou et al., 2011Loizou J.I. Sancho R. Kanu N. Bolland D.J. Yang F. Rada C. Corcoran A.E. Behrens A. Cancer Cell. 2011; 19 (this issue): 587-600Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar provides a valuable framework for future studies aiming at the molecular mechanism by which ATMIN and ATM promote DNA repair and suppress tumor formation. We thank Drs. Richard Baer and Frederick W. Alt for their comments and suggestions. ATMIN Is Required for Maintenance of Genomic Stability and Suppression of B Cell LymphomaLoizou et al.Cancer CellMay 17, 2011In BriefDefective V(D)J rearrangement of immunoglobulin heavy or light chain (IgH or IgL) or class switch recombination (CSR) can initiate chromosomal translocations. The DNA-damage kinase ATM is required for the suppression of chromosomal translocations but ATM regulation is incompletely understood. Here, we show that mice lacking the ATM cofactor ATMIN in B cells (ATMINΔB/ΔB) have impaired ATM signaling and develop B cell lymphomas. Notably, ATMINΔB/ΔB cells exhibited defective peripheral V(D)J rearrangement and CSR, resulting in translocations involving the Igh and Igl loci, indicating that ATMIN is required for efficient repair of DNA breaks generated during somatic recombination. Full-Text PDF Open Archive